Quadria Capital Investment Management

About The Fund

Quadria Capital Investment Management is a leading healthcare private equity firm that specializes in creating value within the healthcare sector in Asia. They primarily target investments in healthcare delivery, life sciences, medical technology, and associated healthcare services spaces. With an investment range of precisely $13,000,000 for each endeavor, they seek opportunities in companies that demonstrate potential for large growth, scalability, clear market differentiation, and strong management teams, aiming to back future market leaders in the region. Quadria Capital has developed a reputation for taking a strategic, industrial approach to their investments, acting as more than just a financial investor by establishing a partnership that includes an exchange of deep domain expertise, operational experience, and an extensive industry network. The firm emphasizes the importance of investing in companies that can scale effectively and strengthen their capabilities. By doing so, they not only aim for exceptional financial returns but also strive to generate meaningful social impact. Some areas of focus include diagnostics, out-of-hospital care, hospital services, medical devices, clinical trials, pharmaceuticals, and the application of artificial intelligence within healthcare. Their portfolio showcases a variety of success stories, such as NephroPlus, Asia’s largest dialysis network, and Maxivision, one of India’s rapidly growing eye care chains. Additionally, Straits Orthopaedics exemplifies their capacity to support companies in MedTech CDMO offering comprehensive manufacturing capabilities. Quadria Capital manages significant assets and has touched the lives of millions, highlighting their commitment to transforming healthcare across Asian markets.